Ekso Bionics Holdings, Inc. (EKSO)

Market Cap	15.54M
Revenue (ttm)	17.68M
Net Income (ttm)	-11.13M
Shares Out	21.59M
EPS (ttm)	-0.64
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	58,390
Open	0.730
Previous Close	0.719
Day's Range	0.700 - 0.735
52-Week Range	0.700 - 3.129
Beta	1.48
Analysts	Strong Buy
Price Target	5.50 (+663.89%)
Earnings Date	Oct 28, 2024

About EKSO

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The com...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2005
• Employees: 72
• Stock Exchange: NASDAQ
• Ticker Symbol: EKSO
• Website: https://www.eksobionics.com

Financial Performance

In 2023, Ekso Bionics Holdings's revenue was $18.28 million, an increase of 41.57% compared to the previous year's $12.91 million. Losses were -$15.20 million, 0.78% more than in 2022.

Analyst Forecast

According to 2 analysts, the average rating for EKSO stock is "Strong Buy." The 12-month stock price forecast is $5.5, which is an increase of 663.89% from the latest price.

Price Target

$5.5

(663.89% upside)

Analyst Consensus: Strong Buy